JNCI Cancer Spectr. 2018 Apr;2(2):pky019
Threonine Tyrosine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy.
Mol Cancer Ther. 2019 Jul 29;:
Benchmarking to the Gold Standard: Hyaluronan-Oxime Hydrogels Recapitulate Xenograft Models with In Vitro Breast Cancer Spheroid Culture.
Adv Mater. 2019 Jul 19;:e1901166
Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trial.
Br J Cancer. 2019 Jul 15;:
MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with 99mTc(I) Tricarbonyl Complex.
Mol Pharm. 2019 Jul 11;:
Cancer Res. 2019 May 29;:
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE).
J Immunother Cancer. 2019 Mar 13;7(1):72
Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1.
Proc Natl Acad Sci U S A. 2019 Feb 15;:
AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer.
Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3604-3613